Coherus BioSciences, Inc. (12)

Browse by Contract Category

Contracts

Separation Agreement, dated as of August 23, 2019, by and between Coherus BioSciences, Inc. and Darlene Horton (Filed With SEC on May 7, 2020)
Form of Confirmation of Base Call Option Transaction (Filed With SEC on April 17, 2020)
Indenture, dated as of April 17, 2020, between Coherus BioSciences, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on April 17, 2020)
License Agreement, dated November 4, 2019, by and between Coherus BioSciences, Inc. and Bioeq IP AG (Filed With SEC on February 27, 2020)
Confidential Litigation Settlement Agreement and Release, dated as of April 30, 2019 between Amgen Inc. and Amgen USA Inc. (collectively Amgen), and Coherus BioSciences Inc (Filed With SEC on August 5, 2019)
First Amendment to Credit Agreement, dated as of April 13, 2020, by and between Coherus BioSciences, Inc. and affiliates of Healthcare Royalty Partners (Filed With SEC on April 14, 2020)
Second Amendment to Convertible Note Purchase Agreement, dated as of April 13, 2020, among Coherus BioSciences, Inc., the Guarantors party thereto, HealthCare Royalty Partners... (Filed With SEC on April 14, 2020)
Description of Coherus Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)
License Agreement, dated January 13, 2020, by and between Coherus BioSciences, Inc. and Innovent Biologics (Suzhou) Co., Ltd (Filed With SEC on February 27, 2020)
Third Amendment, effective May 24, 2019, by and between Hudson 333 Twin Dolphin Plaza, LLC and Coherus BioSciences, Inc (Filed With SEC on November 8, 2019)
Fourth Amendment, effective September 4, 2019, by and between Hudson 333 Twin Dolphin Plaza, LLC and Coherus BioSciences, Inc (Filed With SEC on November 8, 2019)
Credit Agreement, dated as of January 7, 2019, by and among the Company and the Lenders (Filed With SEC on January 11, 2019)